Search

Search Constraints

You searched for: Author/Creator Caputo, Angelika

Search Results

1. [O5–01–02]: RATIONALE FOR SELECTION OF PRIMARY ENDPOINTS IN THE ALZHEIMER PREVENTION INITIATIVE GENERATION STUDY IN COGNITIVELY HEALTHY APOE4 HOMOZYGOTES. (1st July 2017)

3. Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study. Issue 1 (23rd December 2016)

4. API generation program: Active immunotherapy CAD106 slows amyloid deposition in cognitively unimpaired APOE4 homozygotes. (31st December 2021)

5. F2‐03‐04: ASSESSING CLINICAL MEANINGFULNESS OF OUTCOMES IN THE ALZHEIMER'S PREVENTION INITIATIVE GENERATION PROGRAM. (1st July 2019)

6. O4‐08‐03: PSYCHOSOCIAL OUTCOMES OF APOE E4 GENOTYPE DISCLOSURE IN THE GENERATION STUDY. (1st July 2006)

7. O4‐11‐04: ACTIVE Aβ IMMUNOTHERAPY CAD106 PHASE II DOSE‐ADJUVANT FINDING STUDY: SAFETY AND CNS BIOMARKERS. (1st July 2014)